Evidence map›Paper›PMID 36060959›Full record

ArticleFrontiers in endocrinology2022

Emerging phenotypes linked to variants in

Jenifer P Suntharalingham, Miho Ishida, Ignacio Del Valle, Susanne E Stalman, Nita Solanky, Emma Wakeling, Gudrun E Moore, John C Achermann, Federica Buonocore

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. A De Novo Mutation (c.2423A>G) inHuman mutation · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Observational
  15. Emerging phenotypes linked to variants inFrontiers in endocrinology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Jenifer P SuntharalinghamGenetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Miho IshidaGenetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Ignacio Del ValleGenetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Susanne E StalmanDepartment of Pediatrics, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.
Nita SolankyGenetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Emma WakelingNorth East Thames Regional Genetic Service, Great Ormond Street Hospital, London, United Kingdom.
Gudrun E MooreGenetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
John C AchermannGenetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Federica BuonocoreGenetics and Genomic Medicine Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Great Ormond Street Hospital · GBUniversity College London · GBUniversity of Amsterdam · NL

Funding

Wellcome Trust 209328/Z/17/Z
6 · The paper itself

Abstract

Background: Heterozygous Objective: We aimed to investigate: 1) the range of reported Methods: Published data were analyzed, particularly reviewing position/type of variant, pregnancy, growth data, and associated endocrine features. Genetic analysis of Results: To date, Conclusion: MIRAGE syndrome is more phenotypically diverse than originally reported and includes growth restriction and multisystem features, but without adrenal insufficiency. Endocrinopathies might be overlooked or develop gradually, and may be underreported. As clinical features including FGR, severe infections, anemia and lung problems can be non-specific and are often seen in neonatal medicine, SAMD9-associated conditions may be underdiagnosed. Reaching a specific diagnosis of MIRAGE syndrome is critical for personalized management.

Indexed as

Adrenal InsufficiencyHypospadiasMyelodysplastic SyndromesChromosome DeletionChromosomes, Human, Pair 7FemaleFetal Growth RetardationHumansIntracellular Signaling Peptides and ProteinsMalePhenotypePlacentaPregnancySyndromeIntracellular Signaling Peptides and ProteinsSAMD9 protein, humanadrenal insufficiencyendocrinopathiesFGRMIRAGE syndromemyelodysplastic syndrome (MDS)NGSSAMD9

Identifiers

PMID36060959
PMCPMC9433874
OpenAlexW4292416075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.